Pharmaceutical Technology6h
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Trump's controversial administration nominees signal global ramifications for drug regulation, health funding and pharmaceutical investment.
Pharmaceutical Technology6h
Advanz Pharma’s liver disease drug pulled from European market after court hearing
This latest update comes after Advanz secured a suspension of the European Commission’s original revocation in September 2024 ...
Pharmaceutical Technology7h
Trump agency nominations show pharma industry as divided as US
Confirmation of Trump's nominations for appointments is not yet assured and the Senate will vote to approve them early in ...
Pharmaceutical Technology11h
Combatting Infectious Disease: Challenges and Opportunities for Pharma in the Green Transition
The relationship between climate change and infectious disease is raising questions around therapeutic innovation, logistical ...
Pharmaceutical Technology11h
CervoMed’s stock rises as FDA grants orphan drug status to dementia drug
There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.
Pharmaceutical Technology11h
Wait for galactosemia therapy goes on after FDA shuns Applied Therapeutics’ govorestat
The US Food and Drug Administration has declined to approve Applied Therapeutics’ govorestat for classic galactosemia.
Pharmaceutical Technology14h
EC approves GSK’s Menveo vaccine presentation for IMD
The EC has granted approval for presentation of GSK's Menveo vaccine (MenACWY) for invasive meningococcal disease (IMD).